Applied Materials R&D increased by 10.7% to $1.03B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $893.00M to $1.03B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 9.5% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $617.00M | $640.00M | $622.00M | $654.00M | $686.00M | $705.00M | $726.00M | $771.00M | $775.00M | $767.00M | $789.00M | $754.00M | $785.00M | $836.00M | $858.00M | $859.00M | $893.00M | $901.00M | $917.00M | $928.00M | $1.03B |
| QoQ Change | — | +3.7% | -2.8% | +5.1% | +4.9% | +2.8% | +3.0% | +6.2% | +0.5% | -1.0% | +2.9% | -4.4% | +4.1% | +6.5% | +2.6% | +0.1% | +4.0% | +0.9% | +1.8% | +1.2% | +10.7% |
| YoY Change | — | — | — | — | +11.2% | +10.2% | +16.7% | +17.9% | +13.0% | +8.8% | +8.7% | -2.2% | +1.3% | +9.0% | +8.7% | +13.9% | +13.8% | +7.8% | +6.9% | +8.0% | +15.0% |
| Segment | Q2 '26 |
|---|---|
| Semiconductor Systems | $865.00M |
| Applied Global Services | $20.00M |
| Total | $1.03B |